News & Updates

Tenofovir alafenamide (TAF) yields comparable renal outcomes to tenofovir disoproxil fumarate (TDF) in liver transplant (LT) recipients, according to a study presented at The Liver Meeting Digital Experience 2021 by the American Association for the Study of Liver Diseases (AASLD 2021).

Total and differential counts of white blood cell—neutrophils, monocytes, and neutrophil/lymphocyte (NL) ratio—appear to be positively associated with the risk of mortality from all cause as well as from cardiovascular and cerebrovascular diseases, cancer, and respiratory diseases among Taiwanese adults, a study has found.

Bisoprolol does not seem to exert a significant protective effect against perioperative myocardial injury in patients undergoing noncardiac surgery, a recent study has found.

Lysergic acid diethylamide (LSD) may be beneficial for use in psychological-assisted therapy, with a recent study reporting that a 100-mcg dose of LSD enhances the ability of the mind to function efficiently and effectively across a range of situations, according to a study.

Heart failure with preserved ejection fraction (HFpEF) represents a significant unmet medical need. The EMPEROR-Preserved trial aimed to assess the impact of empagliflozin on cardiovascular outcomes in patients with HFpEF. On 27 August 2021, during the hotline session of the 2021 ESC Virtual Congress, the main results of the EMPEROR-Preserved trial were presented by Professor Stefan Anker, principal investigator of the study, and heart failure specialist at Charité Berlin, Germany.

The use of instantaneous wave-free ratio (iFR) to guide revascularization decisions continued to show similar outcomes in terms of all-cause mortality, myocardial infarction (MI), or unplanned revascularization in patients with stable angina or acute coronary syndrome (ACS) compared with fractional flow reserve (FFR) at 5 years, according to the iFR-SWEDEHEART* study presented at TCT 2021.